on initial presentation. Thus, these relapses may be due to new occurrences of disease.
These and other studies of leukaemias and lymphomata were described and the implications of the results for the causes of the malignancies were discussed. (Gripenberg, Levan and Clifford, 1969; Klein et al., 1968; Fialkow et al., 1971) . Similar lines derived from other sources have the property of indefinite proliferation in vitro and may therefore provide a model for the study of at least some aspects of malignancy.
Though little is yet known of the mechanisms involved in the transition from normal lymphocyte to lymphoblastoid cell, there are consistent differences between the two cell types which may provide clues to the nature of the transformation process.
Many established lines have a high level of steroid-binding protein which is also a characteristic of the malignant cells in acute lymphoblastic leukaemia. Preliminary data suggest however that the cytolytic effect of steroids on some lymphoblasts is not dependent solely on the presence of steroid receptors (Gailani et at., 1973; Lippmann, Berry and Thompson, 1974) .
Changes in the expression of surface antigens may have an important role in protection of the host against the proliferation of abnormal lymphoid cells in vivo (Golub et al., 1972; Steel et al., 1974) . The antigenic changes have yet to be fully characterized but HL-A typing reveals both qualitative and quantitative alterations in the expression of transplantation antigens when a cell line becomes established in culture. Similar changes have been detected on leukaemic cells in vivo.
Serial studies on lymphoblastoid lines show progressive shifts in the expression of transplantation antigens (Dick et al., 1973) . Other characteristics, including karyotype, immunoglobulin synthesis and isoenzyme pattern, also change with time in culture (Steel, McBeath and O'Riodan, 1971; Evans, Steel and Arthur, 1974; Povey et al., 1973 Cells from patients with leukaemias were studied using mainly surface immunoglobulins and IgG aggregates as B cell markers, spontaneous rosette formation with sheep red cells and cytotoxic and immunofluorescence tests using heterologous antisera for identifying T cells. The vast majority of chronic lymphocytic leukaemias (CLL) was shown to be a monoclonal B cell proliferation with a maturation block. However biclonal proliferations were encountered and a T cell origin was proven in 3 out of 150 CLL. The abnormal cells in 14 patients with the Sezary syndrome were identified as T cells. In most patients with common acute lymphoblastic leukaemia, no B or T markers were detected at the surface of the abnormal cells. These cells possessed neo antigens reactive with non anti-B antibodies present in antisera to CLL cells. In 30 % of the cases the T nature of the blast cells appeared likely. In 11 other ALL patients a monoclonal B cell proliferation was found. These patients were usually not affected with common ALL and belonged mostly to two specific entities; in 3 cases the blastic proliferation supervented in patients previously affected with common CLL and in 6 cases the blast cells possessed all the cytological features of Burkitt's tumour cells.
B and T cell markers were also assessed in more than 30 cases of non-Hodgkin malignant lymphomata. Well-differentiated lymphocytic lymphomata and nodular lymphomata were found to be of B cell origin. Most of our cases of diffuse poorly differentiated lymphocytic lymphoma behaved as B cell monoclonal malignancies. The so-called reticulum cell sarcomata probably represent a heterogeneous group. In most cases the large malignant cells appeared to be devoid of B or T cell markers. However in one case a strong affinity receptor for IgG was found and was suggestive of a true histiocytic origin. In 3 patients in whom reticulum cell sarcoma supervened on a previous lymphoid malignancy (chronic lymphocytic leukaemia or Waldenstrom macroglobulinaemia) the large sarcoma cells belonged to the B cell series and presumably originated from the same clone as the previous lymphoid proliferation since they bore the same immunoglobulin chains.
SURFACE ANTIGENS OF LEUKAEMIC CELLS M. F. GREAVES, University College London.
Over the past few years the development of the technology for identifying the selective expression of cell surface markers on various populations oflymphoid cells has been a major contribution towards our current understanding of the organization and function of the immune system (Greaves, Owen and Raff, 1973) . In principle this approach should also be applicable to the analysis of leukaemias, lymphomata and in fact malignant cells in general. Thus if a panel of cell surface markers is available which in combination provide a cell surface phenotype characteristic of a particular lymphocyte cell type, say a T cell, then the presence of a similar cell surface profile on a leukaemic cell might be taken to indicate that the latter may have arisen from T cells. This type of investigation might provide a cell refinement to the diagnosis of lymphoreticular malignancies and also insight into the origin and aetiology of the disease (Brown et al., 1974; Harris, 1973) .
Another approach to the identification of leukaemic cells which may hold out even more promise involves the use of antisera which may define cell surface antigens of leukaemic cells which are either entirely restricted to those cells or are at least absent from normal lymphoreticular cells. There is a long history of attempts to produce such discriminating antisera (reviewed in Harris,
